CTRI/2010/091/000264招募中未知
Tacrolimus as induction therapy for proliferative lupus nephritis
I0 个研究点目标入组 20 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Age >18 years
- •2.Diagnosis of SLE fulfilling four or more of the American College of Rheumatology criteria
- •3 Renal biopsy-proven active proliferative lupus nephritis ( Class III, IV or III+V and IV+V) within last 6 months
排除标准
- •1. Pregnancy or pt not willing for contraception
- •3. Initial serum creatinine level ≥2.5mg/dl
- •4.Previous treatment with either CsA or tacrolimus
- •5.Allergy to the calcineurin inhibitors
- •6.Active infection
- •7.Receipt of cytotoxic drug (MMF/Cyclophosphamide/Azathioprine) for more than 2 weeks during the 6 months before study entry
研究者
相似试验
已完成
不适用
The effect of proactive therapy with tacrolimus and betamethasone butyrate on atopic dermatitis: Randomized placebo-controlled studyatopic dermatitisJPRN-UMIN000006955Dept of dermatology, Osaka university90
进行中（未招募）
不适用
Topische Anwendung von Tacrolimus (Protopic) bei verschiedenen Formen des kutanen Lupus erythe-matodes im Rahmen einer klinischen Untersuchung an mehreren nationalen Zentren - entfälltEUCTR2004-005020-41-DEHeinrich Heine Universität Düsseldorf30
已完成
不适用
A randomized controlled study of tacrolimus for the treatment of idiopathic membranous nephropathyIdiopathic membranous nephropathyUrological and Genital DiseasesISRCTN17977921The First Affiliated Hospital of Zhengzhou University (China)120
招募中
2 期
Effect of tacrolimus for patients with refractory Crohn's disease: A randomized, placebo-controlled trial.s diseaseCrohn's diseaseJPRN-UMIN000002796Department of Gastroenterology and Hepatology, Kyoto University50
已完成
不适用
Combination therapy of tacrolimus and intravenous cyclophosphamide for remission induction of lupus nephritislupus nephritisJPRN-UMIN000004893Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University16